Skip to content

    COLLEGIUM PHARMACEUTICAL (COLL) stock price & financials

    View COLL earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance34.6% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $159.30M
    $181.95M
    $177.76M
    $188.00M
    $209.36M
    +31.4%
    $205.45M
    +12.9%
    $193.52M
    +8.9%
    $199.88M
    +6.3%
    Strengthening
    Operating Profit
    $34.84M
    $38.11M
    $21.69M
    $35.10M
    $62.09M
    +78.2%
    $60.76M
    +59.4%
    $30.90M
    +42.5%
    $3.70M
    -89.5%
    Strengthening
    Net Profit
    $9.34M
    $12.54M
    $2.42M
    $11.98M
    $31.51M
    +237.5%
    $16.96M
    +35.3%
    $14.50M
    +499.8%
    -$15.05M
    -225.6%
    Strengthening
    EPS
    $0.29
    $0.39
    $0.08
    $0.38
    $1.00
    +244.8%
    $0.54
    +38.5%
    $0.45
    +462.5%
    $-0.46
    -221.1%
    Strengthening
    Other Income
    Interest
    $18.39M
    $22.65M
    $20.79M
    $20.46M
    $21.77M
    +18.3%
    $19.29M
    -14.8%
    $15.86M
    -23.7%
    $19.52M
    -4.6%
    Weakening
    Depreciation
    Profit before Tax
    $15.58M
    $17.27M
    $3.12M
    $17.02M
    $43.44M
    +178.8%
    $29.04M
    +68.1%
    $18.74M
    +500.3%
    -$13.53M
    -179.5%
    Strengthening
    MarginsOPM
    21.9%
    20.9%
    12.2%
    18.7%
    29.7%
    +35.6%
    29.6%
    +41.1%
    16.0%
    +30.9%
    1.9%
    -90.1%
    Weakening
    Tax
    40.1%
    27.4%
    22.6%
    29.6%
    27.5%
    -31.5%
    41.6%
    +51.7%
    22.6%
    +0.3%
    -11.2%
    -137.9%
    Weakening
    ReturnsROIC
    -9.2%
    -12.3%
    -2.4%
    -11.8%
    -31.0%
    -237.5%
    -16.7%
    -35.3%
    -14.3%
    -499.8%
    14.8%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$146.63M$170.02M$174.12M$186.43M$173.69M$238.95M$70.56M$231.25M$129.47M
    Short-Term Investments$0$71.60M$92.20M$155.43M$0
    Total Current Assets$237.51M$255.72M$277.89M$315.54M$419.99M$537.60M$482.26M$691.41M$608.01M
    Net PP&E$9.27M$20.90M$27.38M$27.14M$26.38M$22.01M$20.15M$16.20M$14.44M
    Goodwill$133.69M$133.86M$162.33M$145.93M$190.18M
    Intangibles$44.26M$29.50M$335.90M$268.72M$567.47M$421.71M$891.40M$669.51M$1.19B
    Total Assets$291.25M$306.30M$643.84M$692.08M$1.17B$1.14B$1.66B$1.66B$2.14B
    LiabilitiesTotal Current Liabilities$189.13M$201.76M$239.45M$279.57M$433.73M$457.92M$509.51M$440.03M$589.86M
    Short-Term Debt
    Long-Term Debt$11.50M$11.50M
    Long-Term Leases$9.44M$8.77M$7.95M$7.11M$6.12M$5.54M$4.13M$3.41M
    Total Liabilities$199.66M$218.87M$457.81M$489.15M$979.29M$947.88M$1.43B$1.36B$1.82B
    EquityCommon Stock & APIC$33.0K$34.0K$35.0K$36.0K$37.0K$38.0K$40.0K$41.0K$41.0K
    Retained Earnings-$337.18M-$359.90M-$333.15M-$256.34M-$281.34M-$233.19M-$164.00M-$101.13M-$101.68M
    Total Equity$91.58M$87.43M$186.03M$202.93M$194.84M$195.43M$228.84M$301.68M$311.91M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$169.39M$27.78M$93.94M$103.56M$124.23M$274.75M$204.98M$329.32M$329.92M
    Cash from Investing-$24.35M-$6.44M-$373.77M-$1.94M-$573.69M-$70.81M-$287.76M-$63.53M-$551.90M
    Cash from Financing-$117.20M$2.04M$286.47M-$89.30M$436.72M-$140.18M-$60.60M-$110.25M$234.11M
    SummaryCapital Expenditure-$5.48M-$6.44M-$5.55M-$1.94M-$1.62M-$461.0K-$1.65M-$1.74M-$1.64M
    Free Cash Flow$163.91M$21.34M$88.40M$101.61M$122.61M$274.29M$203.33M$327.58M$328.28M
    FCF Margin58.5%7.2%28.5%36.7%26.4%48.4%32.2%42.0%40.6%

    Ratios